無料プレビュー

Aquestive Therapeutics, Inc. (AQST) · NASDAQ Global Market

プロフィール

Aquestive Therapeutics is a pharmaceutical company developing and commercializing drugs using proprietary oral film delivery and epinephrine prodrug technologies. Its pipeline includes Anaphylm, a sublingual epinephrine film for anaphylaxis, Libervant, a buccal diazepam film for seizure clusters in young children, and AQST-108, a topical epinephrine gel for alopecia areata. The company manufactures four licensed commercialized products including Suboxone (buprenorphine-naloxone film) and operates manufacturing facilities in Indiana serving domestic and international markets.

主要指標

株価: $4.76 (+3.03%)
時価総額: 6億ドル
PER（今期予想）: -9.7
PBR: -10.5
配当利回り: —
52週レンジ: $2.93 – $7.55
業種: Healthcare / Drug Manufacturers - Specialty & Generic
上場: NASDAQ Global Market
構成銘柄: —

比較会社: TAK Takeda Pharmaceutical Company Limited、TEVA Teva Pharmaceutical Industries Limited、HLN Haleon plc、ZTS Zoetis Inc.、VTRS Viatris Inc.、ITCI Intra-Cellular Therapies, Inc.、CTLT Catalent, Inc.、ELAN Elanco Animal Health Incorporated

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-11-04 · 更新: 2026-10-09